Related Experiment Video
Updated: May 9, 2026
10:19
Evaluation of Biomaterials for Bladder Augmentation using Cystometric Analyses in Various Rodent Models
Published on: August 9, 2012
Evaluation of electrospun bioresorbable scaffolds for tissue-engineered urinary bladder augmentation
Costantino Del Gaudio1, Alberto Vianello, Guido Bellezza
1Department of Industrial Engineering, INSTM Research Unit Roma Tor Vergata, University of Rome Tor Vergata, Rome, Italy. costantino.delgaudio@uniroma2.it
Biomedical Materials (Bristol, England)
|July 18, 2013
Summary
Tissue engineering using novel polymer scaffolds shows promise for treating bladder diseases. These scaffolds promote tissue regeneration, offering a potential new approach for urologic pathologies.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Urology
Background:
- Tissue engineering offers a promising avenue for treating urologic pathologies.
- Bioresorbable polymeric scaffolds are effective platforms for bladder disease treatment and tissue regeneration.
- Electrospun scaffolds composed of poly(ε-caprolactone) and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) were investigated.
Purpose of the Study:
- To evaluate the potential of electrospun scaffolds for urologic tissue engineering.
- To assess the in vivo response of these scaffolds in a urinary bladder augmentation model.
Main Methods:
- Fabrication and characterization of electrospun scaffolds from poly(ε-caprolactone) and poly(3-hydroxybutyrate-co-3-hydroxyvalerate).
- Assessment of scaffold microstructure and mechanical properties.
- In vivo evaluation using a rat model for urinary bladder augmentation.
Main Results:
- Scaffolds demonstrated suitable microstructure and mechanical properties.
- Regenerative urothelium covered up to 50% of scaffolds by 15 days post-implantation.
- Coverage increased to 50-100% by 30 days, with positive results observed at 90 days.
Conclusions:
- Electrospun poly(ε-caprolactone)/poly(3-hydroxybutyrate-co-3-hydroxyvalerate) scaffolds show significant potential for urologic tissue engineering.
- These findings support the application of tissue engineering in treating bladder diseases.
- Further long-term in vivo studies are warranted to fully establish efficacy.
